- Faster access to a person
- Free Community and practical support
- Private-by-default AI architecture
- Separate choice over contribution and clinical use
- A future direct share of eligible data value
Company overview · Updated July 2026
Build better care. Prove the outcomes. Scale what works.
TalkDoc combines an operating mental-health care network with a measured path to AI for psychiatric care. The strategy is to expand access, verify outcomes, and develop clinician-supervised tools that can improve quality and capacity without lowering the standard of care.
Long-term value creation
Better outcomes earn trust. Trust expands distribution. Permissioned data improves validated tools. Better tools help the network serve more people.
A durable business begins with measurable consumer benefit.
Operating proof
A care network first. An AI company built from the results.
Company-reported and unaudited unless stated otherwise. Metrics are intentionally separated from targets.
- 40,000+
- appointments completedReported delivery to date
- Nearly 3,000
- people cared forReported clinical history
- 4
- signed Medi-Cal MCO contractsReported network distribution
- 1.2M
- lives associated with those contractsNot activated members
As of July 2026. “Covered lives” means lives under signed plan contracts; it does not mean active TalkDoc patients, guaranteed referrals, or contracted revenue. Revenue definitions and entity-level reconciliation remain diligence items.
Why this wedge
A signed network creates value only when people can get seen and stay in care.
TalkDoc’s operating wedge is turning payer distribution into real access: reachable members, completed visits, continuity after discharge, and outcomes reported with clear counts and methods.
TodayFee-for-service clinical delivery
The professional corporation bills for care; TalkDoc operates the platform and access layer.
DirectionQuality-linked plan relationships
Base economics plus measured quality upside only after activation data and audited outcomes support it.
The compounding system
Clinical outcomes are the compounding advantage.
The flywheel is valuable only if consent, clinical accountability, and member benefit remain explicit.
- 01Available
Deliver care
Licensed clinicians deliver longitudinal psychiatry through an independent professional entity supported by TalkDoc.
- 02Operating priority
Activate access
Plan-approved outreach, post-discharge follow-up, PCP/FQHC referrals, and a working front door increase engagement.
- 03In development
Measure outcomes
Connect is being built to pair access, engagement, symptom, and utilization measures with clear denominators.
- 04Roadmap
Earn permission
Separate, offer-by-offer member consent—not blanket intake language—creates a defensible contribution path.
- 05Future
Train protected models
Domain models may be improved inside confidential infrastructure after legal, privacy, and clinical gates are met.
- 06Future
Increase capacity
The hypothesis is that validated tools can support clinicians, improve operating efficiency, and create room for more care without automating accountability away.
Aligned economics
Consumer value is the foundation of enterprise value.
- Plan distribution may reduce incremental acquisition cost
- Longitudinal care and community trust may support retention
- Outcome accountability may support payer expansion
- Validated tools may improve clinician capacity and cost-to-serve
- Explicitly permissioned data may become a differentiated learning asset
Diligence-grade status
Live, building, and future are different columns.
Ambition is not counted as traction. This is the current product and business boundary.
AreaStatusDetail
Clinical deliveryOperating
40,000+ appointments reported through the independently owned professional entity; FFS is the current model.
Signed plan distributionOperating
Four Medi-Cal MCO contracts covering 1.2M lives; reach does not equal activated volume.
IronEgg confidential-compute stackStaged rollout
CPU-TEE, encryption, attestation, and short-lived-key components are being introduced in stages; deployed scope varies and requires independent verification.
TalkDoc ConnectRolling out with partner plans
Plan-facing outcomes portal rolling out with partner plans; aggregate outcome measurement and privacy-suppression workflows are still being activated and are not yet a fully live auditor product.
Quality-linked direct contractsPlanned
FFS is the current model; quality-linked amendments depend on activation and audited evidence.
Paid member contributionRoadmap
No general availability, payment pool, or completed consent ledger today.
Outcome evidenceMeasurement in progress
Care totals are company-reported. Hospitalization, symptom, and utilization claims require defined cohorts, reconciled methods, and independent audit before they are treated as proof.
AI for psychiatric careResearch direction
The goal is clinically validated, clinician-supervised AI that can expand excellent care; no autonomous diagnosis or treatment today.
The near-term unlock
Activate the four signed plans before counting the next market.
The constraint is member activation and clinical operations—not a claim that 1.2M lives are already engaged.
Data-driven outreach
Work plan-approved member lists around discharge, ED, and medication continuity needs.
Post-discharge ownership
Build a dependable rapid-follow-up pathway that can improve plan quality measures.
PCP + FQHC channel
Make referrals, warm handoffs, consults, and returned notes operationally simple.
A working front door
Accurate listings, responsive phones, self-scheduling, and language access counter ghost networks.
Technology and evidence boundary
IronEgg protects eligible processing. Connect is designed to prove outcomes.
The long-term hypothesis is not “owned patients.” It is a trusted ability to generate permissioned, longitudinal, outcome-labeled data through care delivery—then use it only inside explicit governance. Paid contribution and member-specific models are not live today.
Confidential processing
Hardware-isolated execution, attestation evidence, encrypted envelopes, and short-lived keys reduce exposure. The deployed scope must remain independently verifiable.
Outcome accountability
Plan-scoped aggregate measures, local decryption, and small-cohort suppression are designed to turn delivery into evidence a quality team can audit.
Operating discipline
Build the reporting, controls, and economics before the market asks for them.
These are long-term operating standards—not a forecast of an IPO, financing, acquisition, valuation, or future performance.
cohorts, methods, claims linkage, and results
repeatable, plan-approved member engagement
entity-level reporting, retention, and contribution margin
recruiting, credentialing, quality, and full panels
measured safety and clinical value before broader use
security, privacy, model, and clinical controls
Institutional readiness scorecard
What the company should be able to report clearly.
- Clinical quality: access, engagement, symptom response, hospital use, and follow-up with defined cohorts.
- Growth quality: covered-to-seen conversion, activation channel, cohort retention, and clinician capacity.
- Revenue quality: entity-level revenue, gross versus net reporting, contribution margin, and acquisition cost.
- Contract quality: payer concentration, renewal, referral mechanics, quality terms, and claims access.
- AI evidence: technical performance, safety, subgroup bias, clinical usefulness, and productivity impact.
- Governance evidence: security assurance, privacy controls, clinical oversight, disclosure controls, and incident readiness.
Important information
No offer or solicitation. This page is provided for general company information only. It does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation regarding any security. Any securities offering, if made, would be made only through definitive, counsel-approved materials to persons legally eligible to receive them.
No transaction or listing commitment. References to operating standards or long-term scale do not indicate that TalkDoc has decided to pursue, will pursue, or will complete an IPO, acquisition, financing, or other transaction. No valuation or liquidity outcome is stated, implied, or promised.
Forward-looking statements. Statements about activation, contracts, margins, product rollout, model development, compensation, expansion, and outcomes are goals or expectations subject to significant risks and uncertainty. Actual results may differ materially.
Company-reported information. Unless expressly stated otherwise, operating figures are company-reported and unaudited as of July 2026. They should not be relied on as a substitute for financial statements, contracts, clinical evidence, security assessments, or legal diligence.
Neutral contact. For company, partnership, media, or institutional information: rishi@talkdoc.com. Contact does not create an offer, allocation, or right to invest.